65 reports

  • Identifying factors impacting market growth

The overdose of pain-relief medicines can also lead to migraine.

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co Ltd
  • Eli Lilly & Co.
  • Market challenges

In 2016, the OTC medicines market reached $##. ## billion in the US alone, where the pain relief segment accounted for ##. ##% of overall market share.

  • Pain Relief
  • World
  • Market Size
  • Sigma-Aldrich
  • Thermo Fisher Scientific, Inc.
  • 4.5 Conclusion
  • 2.6 Comorbidities and Complications

This class of drugs provides potent pain relief.

  • Pain Relief
  • World
  • Market Size
  • Allergan plc
  • Amgen Inc.
  • 7.1.5 RIZAPORT (RIZATRIPTAN BENZOATE)
  • 6.5 JAPAN

SUBJECTS REPORTED PAIN RELIEF IN LESS THAN ## MINUTES, WITH ##% OF SUBJECTS REPORTING PAIN RELIEF WITHIN ONE HOUR OF ADMINISTRATION OF A SINGLE ##MG SUBCUTANEOUS DOSE OF IMITREX INJECTION.

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • BAYER HEALTHCARE
  • Vendor landscape

These are designed particularly for pain relief.

  • Pain Relief
  • World
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.

Rising purchase of generic drugs in the Indian market INDIA PAIN MANAGEMENT DRUGS MARKET Rising incidences of chronic pain in the country is one the major factor towards the increasing purchase of generic drugs for relief of pain falling in the category of musculo

  • Pain Relief
  • World
  • AstraZeneca PLC
  • Endo International plc
  • Pfizer Inc.

In Consumer Health, for the first time a separate division within Bayer AG, the company is focusing R& D activities on dermatologicals, dietary supplements, pain relief, gastrointestinal complaints, allergy relief and cold symptoms, as well as foot and sun care products

  • Pain Relief
  • Bayer AG
  • Herbalife Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • common side effect was medication after taste and nausea in
  • Improvement at two hours in people who took LEVADEX compared to Placebo (2nd pivotal trial)

Executive Summary The report presents the market potential of seven major pipeline drugs meant for the treatment of migraine. These seven drugs that fall in the various categories of Ergotamines, Anti 5-HT Receptor Agonists and Anti-CGRPs by mechanism of action have been recognized as being clinically effective in migraine...

  • Clinical Trial
  • Pain Relief
  • World
  • Forecast
  • Allergan plc

No Relief, by Treatment, 2016 The role of food, vitamin and home treatments Table ##-##: Food, Vitamin and Home Treatments Used to Treat Pain: Got Relief vs.

  • Chronic Disease
  • Chronic Pain
  • OTC
  • Pain Relief
  • DATA PARAMETERS AND REPORT DEFINITIONS (1)
  • REPORT DEFINITIONS (2)

Ibuprofen: Indicated for pain, inflammation and fever, ibuprofen is an NSAID (nonsteroidal anti- Ketoprofen: This is used for the relief of pain and inflammation in rheumatic disease and other musculoskeletal disorders.

  • Pain Relief
  • Demand
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Major market segmentation (2017-18)
  • Supply Chain

Ouch: Many industry players are feeling the pain of strict new regulatory measures Abstract Pain Medication OTC Manufacturing in Australia Industry companies research and develop over-the-counter (OTC) pain-relief medication. Products manufactured by the industry are available without...

  • Analgesic
  • Pain Relief
  • Australia
  • Demand
  • Forecast

Pain Relieving Drugs Market Forecast 2017-2027 ##.

  • OTC
  • Pain Relief
  • World
  • Forecast
  • Market Shares
  • Data parameters and report definitions (1)
  • Report definitions (2)

Different brands accomplish this in different ways: Aleve (Bayer AG), for example, opts for extendedrelease action in its tablets, delivering ## hours of pain relief in one dose of ##mg of naproxen sodium, building on its consistent message of " all day pain

  • Analgesic
  • Pain Relief
  • Therapy
  • World
  • Demand
  • Chapter IV

INJECTABLE LOCAL ANESTHETICS PROVIDE PAIN RELIEF FOR SOME PART OF THE BODY DURING SURGERY, DENTAL PROCEDURES, OR OTHER MEDICAL PROCEDURES.

  • Pain Relief
  • China
  • Demand
  • Trade
  • Yichang Humanwell Pharmaceutical Co.

These medications provide short-term relief but are not able to eliminate the cause of pain.

  • Pain Relief
  • World
  • AstraZeneca PLC
  • Endo International plc
  • Pfizer Inc.

(USA) ##.

  • Pain Relief
  • China
  • United States
  • Demand
  • Market Shares

(USA) ##.

  • Analgesic
  • Opioid
  • Pain Relief
  • United States
  • Market Shares
  • Namenda (memantine)
  • Sales of Top Anti-Migraine Products in 2017

The company' s Respiratory and Personal Care include Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp and ChapStick.

  • Hospital
  • Pain Relief
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.
  • REGIONAL OVERVIEW

PASSPORT ## STEADY REGIONAL GROWTH DRIVEN BY CHINA REGIONAL OVERVIEW The accelerated ageing of the population in China and Japan contributed to the region' s steady growth over the past ## years, as elderly consumers consider pain relief the major and first problem to solve and

  • Pain Relief
  • APAC
  • China
  • Kowa Co., Ltd.
  • Sanofi S.A.

THE NEED FOR SELF-ADMINISTRATION IS EVIDENT IN EMERGENCY SITUATIONS AND IN CONDITIONS, SUCH AS LIFETHREATENING ALLERGY INDICATIONS, IMMEDIATE PAIN RELIEF FOR WOUNDED MILITARY PERSONNEL DURING WARTIME AND SEVERAL OTHER CONDITIONS.

  • Neurological Disorder
  • Pain Relief
  • World
  • Forecast
  • Antares Pharma, Inc.

The prominent features of this report are - ##.

  • Hormone
  • Maternal Health
  • Pain Relief
  • World
  • Social Conditions
  • Drug Details
  • Trial Results

Tension -Type Headache Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, ?Tension -Type Headache Global Clinical Trials Review, H1, 2015" provides data on the Tension -Type Headache clinical trial scenario. This report provides elemental information and data relating to the clinical trials...

  • Pain Relief
  • World
  • Bayer AG
  • GlaxoSmithKline plc
  • Tonix Pharmaceuticals Holding Corp.
  • REGIONAL OVERVIEW

PASSPORT ## REGIONAL OVERVIEW REGIONAL OVERVIEW BY CATEGORY The trend towards topical analgesics continues across the region, as consumers grow more wary of ingesting chemicals and gravitate more toward topical remedies, which are perceived as providing the same degree of pain

  • Pain Relief
  • Demand
  • Bayer AG
  • Procter & Gamble Company
  • Unilever PLC

IN JULY 2014, GSK RECALLED PANADOL ADVANCE ## CT PAIN RELIEF PRODUCTS FROM PUERTO RICO CONSUMERS, AS IT LACKED A CHILD RESISTANT FEATURE AND IS NOT LABELED AS A PRODUCT " FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN".

  • Pain Relief
  • Canada
  • North America
  • United States
  • Mylan Inc.
  • interviews
  • Passport 2

Since October 2014, Canadian golf icon and eight-time PGA Tour winner Mike Weir has been representing the Aleve brand in Canada as a pain relief product for arthritis.

  • OTC
  • Pain Relief
  • Canada
  • Demand
  • Bayer AG

The prominent features of this report are - ##.

  • Maternal Health
  • Pain Relief
  • World
  • Social Conditions
  • Biogen Idec Inc.
  • BAYER HUNGÁRIA KFT

Due to continuous innovation activity of Bayer AG, the company' s share is set to rise and it is expected to gain further share after the launch of the new Aspirin product offering twice as fast pain relief due to the micro-active technology and rapid dispersing of the medicine

  • Pain Relief
  • Pharmaceutical
  • Hungary
  • Demand
  • Bayer AG
  • SEP 05, 2008: NEURAXON'S NXN-188 DEMONSTRATES PAIN RELIEF IN MIGRAINE WITH AURA
  • Neurophyxia B.V. is an innovative clinical stage drug development company, focusing on disorders affecting the newborn child announces the start of formal preclinical development of 2-IB (manufacturing and safety studies).

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H1 2018 Summary Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl...

  • Pain Relief
  • United States
  • World
  • Product Initiative
  • NeurAxon, Inc.
  • GSK- Revenues from Imigran/Imitrex Migraine Drugs Brands
  • 9.3 GLAXOSMITHKLINE (GSK)

Scope of the report The report titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)” provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value, segmentation, types of diagnosis and treatment for migraine. It also discusses key growth drivers...

  • Pain Relief
  • World
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • SENSUS RLS - USE OF WEARABLE PAIN RELIEF TECHNOLOGY IN RESTLESS LEG SYNDROME
  • FEB 21, 2017: NEUROMETRIX ANNOUNCES AVAILABILITY OF QUELL WEARABLE PAIN RELIEF TECHNOLOGY AT BEST BUY

Summary NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNCheck and advance NCS system. Its SENSUS...

  • Pain Relief
  • United States
  • Company Financials
  • Product Initiative
  • NeuroMetrix, Inc.